Huafon Chemical Co., Ltd.

SZSE:002064.SZ

6.91 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Revenue 26,196.69925,884.10628,367.20214,723.88313,785.2484,435.7144,149.6842,844.2282,547.3622,361.5372,372.4421,727.3141,414.1251,627.8511,195.8821,015.6771,433.511763.033540.087619.705535.01
Cost of Revenue 22,350.42321,242.01917,388.87611,067.01410,474.2093,422.2083,292.0872,345.6161,874.7781,614.2361,827.9921,554.7121,200.9381,102.515966.941831.991794.621630.455437.297398.367311.086
Gross Profit 3,846.2764,642.08710,978.3263,656.8683,311.0391,013.506857.597498.612672.584747.302544.45172.602213.187525.336228.941183.686638.89132.578102.79221.338223.924
Gross Profit Ratio 0.1470.1790.3870.2480.240.2280.2070.1750.2640.3160.2290.10.1510.3230.1910.1810.4460.1740.190.3570.419
Reseach & Development Expenses 901.4291,061.6011,025.694509.531530.096170.398128.21663.50675.86382.04289.10260.13144.89758.94436.32734.51500000
General & Administrative Expenses 88.14695.22784.14475.35190.3346.29245.17754.95352.5323.30826.61325.94626.4621.74418.35525.27155.47624.74331.91727.34828.635
Selling & Marketing Expenses 194.057169.269157.614125.692379.82688.65282.71588.60957.33536.77632.74126.28822.43625.86424.18820.26719.08312.877.9857.0535.858
SG&A 553.55264.496241.758201.043470.156134.945127.893143.562109.86560.08459.35552.23448.89547.60842.54345.53874.55837.61339.90234.40134.494
Other Expenses 22.484318.892436.607244.319181.879-1.12224.0715.1548.669.43910.77749.1599.94413.18417.7885.97512.0243.8032.151-0.011.197
Operating Expenses 1,432.4941,644.9891,704.06954.8931,182.131431.02350.123319.607306.173261.92222.547164.54136.018158.675106.733104.13683.58341.38442.95938.51738.706
Operating Income 2,413.7813,203.1599,247.2862,641.7122,132.209504.672421.321-295.692307.629464.978300.719-22.65846.497358.171105.83570.107542.76381.99465.112180.043174.188
Operating Income Ratio 0.0920.1240.3260.1790.1550.1140.102-0.1040.1210.1970.127-0.0130.0330.220.0880.0690.3790.1070.1210.2910.326
Total Other Income Expenses Net 104.374-21.806-90.833-27.722-53.023-78.936-62.083-459.557-50.143-10.97-9.87218.435-20.754.6631.41-3.468-0.52-6.8046.04-3.782-9.833
Income Before Tax 2,518.1553,181.3539,156.4532,613.992,079.185503.55445.391-280.552316.268474.412312.03126.49856.419371.323123.61876.082554.78885.09366.567179.536175.385
Income Before Tax Ratio 0.0960.1230.3230.1780.1510.1140.107-0.0990.1240.2010.1320.0150.040.2280.1030.0750.3870.1120.1230.290.328
Income Tax Expense 139.687339.4121,220.273335.226238.42158.32959.89623.25762.14163.74235.2688.0955.63351.51616.252-87.556174.32525.67116.49154.66241.514
Net Income 2,478.4642,843.9727,936.6952,279.1321,841.482445.221385.496-303.809254.127410.67276.76218.40350.786319.807107.366163.637380.46259.42250.076124.874133.871
Net Income Ratio 0.0950.110.280.1550.1340.10.093-0.1070.10.1740.1170.0110.0360.1960.090.1610.2650.0780.0930.2020.25
EPS 0.50.581.710.490.430.10.23-0.180.150.240.190.010.0350.220.0750.110.260.0480.0450.110.12
EPS Diluted 0.50.581.710.490.430.10.23-0.180.150.240.190.010.0350.220.0750.110.260.0480.0450.110.12
EBITDA 3,721.2824,488.28310,332.213,588.9662,852.842878.176834.491455.093596.557656.334495.272210.073221.771525.076284.498211.353654.669163.31125.093238.407237.964
EBITDA Ratio 0.1420.1730.3640.2440.2070.1980.2010.160.2340.2780.2090.1220.1570.3230.2380.2080.4570.2140.2320.3850.445